About this episode

The episode discusses the latest SYNGAP1 Census results and fundraising efforts for patient support.

#Future4Ford. 2Q26 #SYNGAP1Census = 1,806 Patients (+45) $CAMP #ValproateDemandBetter #S10e212 Saturday, July 4, 2026 - Week 27 #Future4Ford! Already at $3,500+! Share. Thank you to the Family. This is the model for newly diagnosed, call us, set up a page, help us help your loved one. cureSYNGAP1.org/4Ford CENSUS - 1,806 https://curesyngap1.org/blog/syngap1-census-2026-update-45-q2-total-1806/ Per https://docs.google.com/spreadsheets/d/1oJwMysR2wyTxe91zLlKJglNa0NySPxkBF0PRiV6mBmM/edit?usp=sharing, no change in Germany, UK, or Netherlands. This is clearly wrong. MERCH - 9 days left! New t-shirts! Buy for everyone! There are some funny ones this year and the classics. cureSYNGAP1.org/Bonfire CAMP4 has been busy! Meeting with one of our families: https://www.linkedin.com/posts/syngap1-share-7473374060614201345-SeKO/ Shoutout on NASDAQ: https://www.linkedin.com/posts/camp4-therapeutics_syngap1awareness-regrna-syngap1-activity-7474823632972820480-UMqi $CAMP closed at $4.43 yesterday. https://www.google.com/finance/beta/quote/CAMP:NASDAQ BONES – This is not medical advice, I am not a doctor. Talk to a doctor AND know your facts…

Topics covered

• SYNGAP1 Census
• Patient Advocacy
• Valproate
• Fundraising
• Community Support
• Health Awareness

Keywords

• SYNGAP1
• Census
• Valproate
• CAMP
• fundraising
• patient support
• health awareness

Mentioned in this episode

Organizations: Syngap Research Fund, cureSYNGAP1.org, CAMP4, NASDAQ

Products: Valproate

Places: Germany, UK, Netherlands

More episodes of CURE SYNGAP1 PODCAST aka SYNGAP10

• We need a #SYNGAP1 mouse lab? #BIO2026 #MDBR 19 days for Merch. #GeneticTesting #ASOwebinar #S10e211 · June 26, 2026 · 10 min
• #ILoveSomeoneWithSYNGAP1. June 21 is SYNGAP1 Awareness day. $159 rooms at the GrandHyatt! #S10e210 · June 19, 2026 · 10 min

Explore listener stats, chart rankings, contacts and more on the CURE SYNGAP1 PODCAST aka SYNGAP10 podcast page.